The Norwegian Institute of Public Health would like to procure Hepatitis B vaccines for the national vaccination programme. The procurement is carried out on behalf of the Ministry of Health and Care Services (HOD).
The aim of the procurement is to enter into a contract for the delivery of a vaccine against Hepatitis B for the Norwegian child vaccination programme.
The Norwegian Institute of Public Health would like to procure Hepatitis B vaccines for the national vaccination programme. The procurement is carried out on behalf of the Ministry of Health and Care Services (HOD).
The aim of the procurement is to enter into a contract for the delivery of a vaccine against Hepatitis B for the Norwegian child vaccination programme.
Children and adolescents in defined risk groups have long been required to be vaccinated against hepatitis B. Norway introduced general Hepatitis B vaccinations in 2016 (applies to children born after 01.11.2016). The target group for pure Hepatitis B vaccines will therefore primarily be previously non-vaccinated children and adolescents in risk groups, born before 01.11.2016, that move to Norway.
The childhood vaccination programme includes everyone under 20 years. Available vaccines against Hepatitis B in Norway are found in two dose sizes depending on the persons age (children and adult). The procurement concerns both dose sizes. After the introduction of general vaccination, the need for ‘children's doses’ is decreasing, but the need for ‘adult doses’ is relatively stable.
The procurement concerns the delivery of vaccines against Hepatitis B (ATC code: J07B C01) for vaccinating children and adolescents in defined risk groups in the Norwegian child vaccination programme.
The following estimates for the annual number of doses required by the Norwegian Public Health Institute are based on statistics for actual distributed doses in the last two years.
The estimated annual need for doses for children will be approx. 5000 doses (per calendar year).
The estimated annual need for doses for adults will be approx. 3000 doses (per calendar year).
The estimated total scope for the contract period, with the full extension of the contract period (option), is estimated to be approx. 20,000 doses for children, and approx. 12,000 doses for adults.
The contest has price as the only award criterium.
FHI received two tenders in the contest. A contract will be awarded to and signed with one tenderer.